Tag: italfarmaco

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

MILAN, Italy, June 06, 2025 – Italfarmaco S.p.A. announced today that the…

GlobeNews Wire
By GlobeNews Wire